The emergence of a novel coronavirus known as SARS-CoV-2 caused the worldwide outbreak of the coronavirus disease 2019 (COVID-19). The presence of SARS-CoV-2 in infected people causes common symptoms that COVID-19 and influenza both share. In some cases, it initiates various protective responses that lead to pneumonia and acute respiratory distress syndrome. Strengthening pandemic management and response for both COVID-19 and influenza with rapid point of care testing solutions are becoming the new norm to make the world safer.
Research shows that, Cardiovascular disease and Diabetes (CVD & DM), two major diseases of Chronic diseases, are closely related. The increment of 1 unit (%) of HbA1c increased cardiovascular mortality by 52% and 7% in type 1 and 2 diabetic subjects, respectively. According to World Heart Federation, cardiovascular disease is the leading cause of mortality for people who live with diabetes. To complete the CVD & DM management, we are proud to include Blood Glucose, Total Cholesterol, HbA1c, Lipid and integrated measurements in our extensible platform to help users manage their health with convenience and communicability.Product List:
- PixoTest® Blood Glucose Monitoring System
- PixoTest® PixoTest® POCT System for HbA1c, Lipid Panel
There are some health issues that are unique to women. An obstetrical disorder may affect women’s pregnancy and childbirth. A gynecological disorder may affect female reproduction organs, including menstrual cycle, ovulation and related issues.
To broaden women’s health management, PixoTest® technology provides semi-quantitative LH Ovulation test results to help users have a better fertility plan.